Olr1-KO Mouse
一般名
Olr1-KO
製品ID
S-KO-00574
背景情報
C57BL/6NCya
系統ID
KOCMP-108078-Olr1-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Olr1-KO Mouse(カタログ番号S-KO-00574)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Olr1-KO
系統ID
KOCMP-108078-Olr1-B6N-VA
遺伝子名
製品ID
S-KO-00574
遺伝子別名
LOX-1, SR-EI, Scare1
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conventional knockout
染色体
Chr 6
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000032265
NCBIトランスクリプトID
NM_138648
ターゲット領域
Exon 5~6
有効領域の大きさ
~4.8 kb
遺伝子研究の概要
Olr1, also known as oxidized LDL receptor 1, encodes LOX-1, LOXIN, and OLR1D4 transcript variants. It is a lectin-like scavenger receptor that recognizes ligands such as oxidized low-density lipoprotein (ox-LDL). OLR1 is involved in multiple biological processes, especially those related to cardiovascular and metabolic disorders [2,3]. In the cardiovascular system, it is associated with pathways leading to atherosclerotic plaque formation [3].
In cancer research, OLR1 shows significant implications. In pancreatic cancer, OLR1 promotes cell proliferation and metastasis both in vitro and in vivo by increasing HMGA2 transcription via upregulating c-Myc expression, and patients with high expression of the OLR1-c-Myc-HMGA2 axis have a worse prognosis [5]. In head and neck squamous cell carcinoma (HNSCC), OLR1 is highly expressed in tumors, related to advanced clinicopathological factors and unfavorable outcomes. High OLR1 expression is associated with immune escape and less benefit from immune checkpoint inhibitor therapy, and may affect epithelial-mesenchymal transition (EMT), stemness, and cuproptosis resistance [1,6]. In esophageal cancer, OLR1 suppresses autophagic cell death through the MAP2K/MEK-MAPK/ERK-TFEB pathway to promote tumorigenesis [7]. In addition, OLR1 gene polymorphisms are associated with the risk of coronary artery disease (CAD), and specific SNPs like rs1050283 and rs3736235 in the haplotype block are more significantly related to CAD risk [2]. There is also an association between OLR1 gene variations and polycystic ovary syndrome (PCOS) as well as atherosclerotic risk factors [4].
In conclusion, OLR1 is a multifunctional gene involved in both cardiovascular and cancer-related biological processes. Studies on OLR1, especially through in vivo models in cancer and genetic polymorphism analysis in cardiovascular diseases, have revealed its role in disease development, providing potential targets for treatment in these disease areas.
References:
1. Wu, Lei, Liu, Yuantong, Deng, Weiwei, Bu, Linlin, Chen, Lei. 2023. OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC. In International journal of molecular sciences, 24, . doi:10.3390/ijms241612904. https://pubmed.ncbi.nlm.nih.gov/37629087/
2. Salehipour, Pouya, Rezagholizadeh, Farzaneh, Mahdiannasser, Mojdeh, Kazerani, Reihane, Modarressi, Mohammad Hossein. 2021. Association of OLR1 gene polymorphisms with the risk of coronary artery disease: A systematic review and meta-analysis. In Heart & lung : the journal of critical care, 50, 334-343. doi:10.1016/j.hrtlng.2021.01.015. https://pubmed.ncbi.nlm.nih.gov/33524863/
3. Pirillo, Angela, Norata, Giuseppe Danilo, Catapano, Alberico Luigi. 2013. LOX-1, OxLDL, and atherosclerosis. In Mediators of inflammation, 2013, 152786. doi:10.1155/2013/152786. https://pubmed.ncbi.nlm.nih.gov/23935243/
4. Sahin, Serap Baydur, Nalkiran, Ihsan, Ayaz, Teslime, Calapoglu, Tugba, Sevim Nalkiran, Hatice. 2023. Genetic variations in OLR1 gene associated with PCOS and atherosclerotic risk factors. In Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 71, 113-123. doi:10.1177/10815589221141831. https://pubmed.ncbi.nlm.nih.gov/36647317/
5. Yang, Gang, Xiong, Guangbing, Feng, Mengyu, Zhang, Taiping, Zhao, Yupei. 2020. OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2. In Molecular cancer research : MCR, 18, 685-697. doi:10.1158/1541-7786.MCR-19-0718. https://pubmed.ncbi.nlm.nih.gov/32019809/
6. Zhang, Peng, Zhao, Yan, Xia, Xin, Yu, Shuting, Chen, Xingming. 2023. Expression of OLR1 gene on tumor-associated macrophages of head and neck squamous cell carcinoma, and its correlation with clinical outcome. In Oncoimmunology, 12, 2203073. doi:10.1080/2162402X.2023.2203073. https://pubmed.ncbi.nlm.nih.gov/37089448/
7. Li, Can, Wang, Lan. 2021. TFEB-dependent autophagy is involved in scavenger receptor OLR1/LOX-1-mediated tumor progression. In Autophagy, 18, 462-464. doi:10.1080/15548627.2021.2012970. https://pubmed.ncbi.nlm.nih.gov/34936535/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
